295 related articles for article (PubMed ID: 25541960)
1. Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema.
Liegl R; Langer J; Seidensticker F; Reznicek L; Haritoglou C; Ulbig MW; Neubauer AS; Kampik A; Kernt M
PLoS One; 2014; 9(12):e113981. PubMed ID: 25541960
[TBL] [Abstract][Full Text] [Related]
2. 3-year-data of combined navigated laser photocoagulation (Navilas) and intravitreal ranibizumab compared to ranibizumab monotherapy in DME patients.
Herold TR; Langer J; Vounotrypidis E; Kernt M; Liegl R; Priglinger SG
PLoS One; 2018; 13(8):e0202483. PubMed ID: 30138384
[TBL] [Abstract][Full Text] [Related]
3. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
[TBL] [Abstract][Full Text] [Related]
4. Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
Payne JF; Wykoff CC; Clark WL; Bruce BB; Boyer DS; Brown DM;
Ophthalmology; 2017 Jan; 124(1):74-81. PubMed ID: 27836430
[TBL] [Abstract][Full Text] [Related]
5. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Mitchell P; Bandello F; Schmidt-Erfurth U; Lang GE; Massin P; Schlingemann RO; Sutter F; Simader C; Burian G; Gerstner O; Weichselberger A;
Ophthalmology; 2011 Apr; 118(4):615-25. PubMed ID: 21459215
[TBL] [Abstract][Full Text] [Related]
6. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
Lang GE; Liakopoulos S; Vögeler J; Weiß C; Spital G; Gamulescu MA; Lohmann C; Wiedemann P
Acta Ophthalmol; 2018 May; 96(3):e377-e385. PubMed ID: 29090846
[TBL] [Abstract][Full Text] [Related]
7. Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME.
Berger A; Sheidow T; Cruess AF; Arbour JD; Courseau AS; de Takacsy F
Can J Ophthalmol; 2015 Jun; 50(3):209-16. PubMed ID: 26040221
[TBL] [Abstract][Full Text] [Related]
8. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
Mukkamala L; Bhagat N; Zarbin MA
Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
[TBL] [Abstract][Full Text] [Related]
10. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.
Payne JF; Wykoff CC; Clark WL; Bruce BB; Boyer DS; Brown DM;
Am J Ophthalmol; 2019 Jun; 202():91-99. PubMed ID: 30771333
[TBL] [Abstract][Full Text] [Related]
12. 12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulation.
Barteselli G; Kozak I; El-Emam S; Chhablani J; Cortes MA; Freeman WR
Br J Ophthalmol; 2014 Aug; 98(8):1036-41. PubMed ID: 24723616
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
Elman MJ; Ayala A; Bressler NM; Browning D; Flaxel CJ; Glassman AR; Jampol LM; Stone TW;
Ophthalmology; 2015 Feb; 122(2):375-81. PubMed ID: 25439614
[TBL] [Abstract][Full Text] [Related]
14. Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial.
Kanar HS; Arsan A; Altun A; Akı SF; Hacısalihoglu A
Indian J Ophthalmol; 2020 Jan; 68(1):145-151. PubMed ID: 31856493
[TBL] [Abstract][Full Text] [Related]
15. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
Solaiman KA; Diab MM; Dabour SA
Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
[TBL] [Abstract][Full Text] [Related]
16. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
Schmidt-Erfurth U; Lang GE; Holz FG; Schlingemann RO; Lanzetta P; Massin P; Gerstner O; Bouazza AS; Shen H; Osborne A; Mitchell P;
Ophthalmology; 2014 May; 121(5):1045-53. PubMed ID: 24491642
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
Pearce I; Banerjee S; Burton BJ; Chakravarthy U; Downey L; Gale RP; Gibson J; Pagliarini S; Patel J; Sivaprasad S; Andrews C; Brittain C; Warburton J;
Ophthalmology; 2015 Sep; 122(9):1811-9. PubMed ID: 26150052
[TBL] [Abstract][Full Text] [Related]
18. Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.
Pielen A; Mirshahi A; Feltgen N; Lorenz K; Korb C; Junker B; Schaefer C; Zwiener I; Hattenbach LO;
Acta Ophthalmol; 2015 Feb; 93(1):e29-37. PubMed ID: 25042729
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
Solaiman KA; Diab MM; Abo-Elenin M
Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.
Tan MH; McAllister IL; Gillies ME; Verma N; Banerjee G; Smithies LA; Wong WL; Wong TY
Am J Ophthalmol; 2014 Jan; 157(1):237-247.e1. PubMed ID: 24112635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
